3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
2
Terminated
2
Completed
1
Active not recruiting
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Ovarian Neoplasms
11
Peritoneal Neoplasms
9
Colorectal Neoplasms
3
Neoplasms
2
Hyperthermia
2
Glioma
2
Glioblastoma
2
Gastrointestinal Neoplasms
2
Fallopian Tube Neoplasms
2
Colonic Neoplasms
2
Brain Neoplasms
2
Adrenocortical Carcinoma
2
Wilms Tumor
1
Stomach Neoplasms
1
Sarcoma
1
Rhabdomyosarcoma
1
Retroperitoneal Neoplasms
1
Recurrence
1
Pseudomyxoma Peritonei
1
Postoperative Complications
1
Peritoneal Cavity Cancer
1
Oligodendroglioma
1
Neuroblastoma
1
Neoplasm, Residual
1
Mesothelioma
1
Lymphatic Metastasis
1
High Grade Serous Ovarian
1
Gliosarcoma
1
Desmoplastic Small Round Cell Tumor
1
Carcinoma, Ovarian Epithelial
1
Interventions
Carboplatin
69
Paclitaxel
63
Cisplatin
32
Topotecan
29
Gemcitabine
21
Docetaxel
20
Cyclophosphamide
18
Filgrastim
17
liposomal doxorubicin
15
Peripheral Blood Stem Cell Transplantation
15
Bevacizumab
14
sargramostim
11
Taxes
10
Drug Therapy
10
Therapeutics
7
Psychiatric Rehabilitation
7
Immunohistochemistry
7
Erlotinib Hydrochloride
7
Amifostine
7
Melphalan
6
Chemotherapy, Adjuvant
6
rucaparib
5
pembrolizumab
5
mirvetuximab soravtansine
5
ixabepilone
5
Surgical Procedures, Operative
5
Mass Spectrometry
5
Interleukin-12 Subunit p35
5
Flow Cytometry
5
Etoposide
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Carcinoma, Ovarian Epithelial
×
Cytoreduction Surgical Procedures
×
Clear all
NCT00008138
2016-01-08
S0009
SWOG Cancer Research Network
Phase 2
Completed
62 enrolled
9 charts